Etasr

Etasr has been studied in 1 paper since 2026: none in people yet, 1 in cells; 1 in the past year. No study of it in people or animals has been published yet. The newest story, Nov 13, 2026: “Engineered tool improves DNA editing in mammalian cells”.

Intervention

1 paper studies it2 findingsUpdated Nov 13, 2026

1 new paper in 30 daysSee all 1 papers on etasr

At a glance

The findings reach mice, none yet in people. 1 lab.

None of its findings points the other way.

1 lab

Cells1

What did studies of etasr find?

Studies of etasr measured 2 outcomes: Hpd disruption and genome editing efficiency.

Hpd disruption

upin M. cells1

1 study

Etasr induces Hpd disruption in vivo.
“single-AAV delivery enabled efficient Hpd disruption in vivo”
Animalsin vivosingle-AAV delivery
Engineered tool improves DNA editing in mammalian cells
bioRxivNov 13, 2026Preprint

Genome editing efficiency

upin M. cells cells1

1 study

Etasr increases genome editing efficiency in M. cells cells (compared with original ParTasR) (4.29% to 48.94%; average 26.52-fold increase).
“eTasR increased mammalian editing efficiency from the original 4.29% to 48.94% with an average 26.52-fold increase”
Cellscompared with original ParTasRmammalian cells
Engineered tool improves DNA editing in mammalian cells
bioRxivNov 13, 2026Preprint

Latest

1 paper in 12 months

bioRxivNov 13

Engineered tool improves DNA editing in mammalian cells

Editing efficiency rose from 4.29% with the original tool to 48.94% with the engineered version in experiments with mammalian cells.Editing efficiency rose from 4.29% with the original tool to 48.94% with the engineered version in experiments with mammalian cells.

Preprint: animal cell studyInterventions

Paper